Tissue Banking involves the collection, preservation, and storage of biological tissues for various purposes, including medical research, transplantation, and education. Tissues obtained from donors, both living and deceased, are processed, documented, and stored under controlled conditions to maintain their viability and functionality. In the context of organ transplantation, tissue banking plays a crucial role in ensuring a readily available supply of organs for transplantation procedures, enhancing the chances of successful grafts. Additionally, tissue banks are pivotal in supporting medical research by providing researchers with a valuable resource for studying diseases, developing new therapies, and conducting experiments. Cryopreservation techniques are often employed to store tissues for extended periods, allowing researchers to access a diverse range of tissues over time. Ethical considerations, privacy, and informed consent are fundamental aspects of tissue banking practices. The establishment of standardized protocols and quality control measures is essential to ensure the safety and efficacy of stored tissues. Tissue banks contribute significantly to advancements in medicine, fostering breakthroughs in regenerative medicine, tissue engineering, and personalized medicine. As technology and biobanking practices evolve, tissue banking continues to be a critical component in medical progress and the improvement of healthcare outcomes.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States